Francis Kalule Kizito
ID:
|
Molecular identification of benzimidazole resistance associated with beta-tubulin gene in adult Haemonchus contortus worms from goats slaughtered in Kalerwe abattoir in Uganda
REFNo: A133ES
1. To identify common intestinal parasites from goats slaughtered in Kalerwe abattoir in Uganda
2. To determine the prevalence of Haemonchus contortus species identified from goats slaughtered in Kalerwe abattoir in Uganda.
3. To determine the importance of ITS- 2 gene in analyzing genetic diversity among isolates of Haemonchus contortus.
4. To determine the frequency of benzimidazole resistant SNPS F200Y, F167Y and E198A in the partial β-tubulin isotype 1 gene of Haemonchus contortus identified from goats slaughtered in Kalerwe abattoir in Uganda.
|
Uganda |
2021-07-07 |
2024-07-07 |
Agricultural Sciences |
Non-Clinical Trial |
Degree Award |
|
Noeline Nakasujja
ID: UNCST-2019-R001428
|
ASSESSING THE IMPLEMENTATION OF THE POLICY AND REGULATIONS AGAINST SEXUAL HARASSMENT (PRASH) AT MAKERERE UNIVERSIT
REFNo: SS925ES
1. To assess the extent to which the recommendations from the 2018 committee on SM&H, and the 2018 amendments to PRASH have been implemented.
2. To conduct a dialogue among the University’s key stakeholders focused on addressing SM&H and creating a safe working and learning environment at the Makerere University.
3. To develop a set of recommendations to improve the monitoring and implementation of PRASH
|
Uganda |
2021-07-07 |
2024-07-07 |
Social Science and Humanities |
Non-Clinical Trial |
Non-degree Award |
|
Daniel Murokora Murokora
ID: UNCST-2024-R002689
|
Transition To Scale: Using the FREO2 Social Enterprise model and technology to scale up access to Oxygen in Uganda
REFNo: HS1238ES
The aim of this project is to evaluate the impact of a reliable oxygen system on improving a) oxygen reliability and affordability, b) clinical outcomes for children.
With a strong emphasis on clinical and technical training, the project activities should:
a) Improve the availability of oxygen, the detection of hypoxaemia, and the access of a sick child to oxygen when they require it
b) Reduce patient and health system costs of oxygen
c) Understand appropriateness, acceptability, and feasibility of the system in the specific context of health facilities in Western Uganda
|
Uganda |
2021-07-06 |
2024-07-06 |
Medical and Health Sciences |
|
Non-degree Award |
|
Achilles Katamba
ID: UNCST-2019-R000540
|
Evaluation of Xpert® MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second line drugs
REFNo: HS1395ES
Secondary: To evaluate factors for lab uptake o Training needs o Recording and Reporting Needs o Error rates o Proportion of results interpretable o TAT o Work flow,Assess sensitivity and specificity of Xpert® MTB/XDR test in previously stored sputum samples (previously stored) compared to the WHO-endorsed genotypic (MTBDRplus and MTBDRsl) method as a gold standard.,Assess sensitivity and specificity of Xpert® MTB/XDR test in previously stored sputum samples (previously stored) compared to the WHO-endorsed MGIT960 culture-based drug susceptibility method as a gold standard,The main objective is to independently validate the performance of the Xpert® MTB/XDR test for susceptibility testing of MTB among presumptive XDR-TB patients. The test performance indicators will be compared with current standard drug susceptibility test methods including the MGIT 960 liquid culture drug susceptibility (DST) systems, Line probe Assay and Whole genome sequencing. ,
|
Uganda |
2021-07-06 |
2024-07-06 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Frederick Mubiru Edward
ID:
|
Market Research on Service Delivery Implications for a 4-month Depot Medroxyprogesterone Acetate Subcutaneous (DMPA-SC) Product
REFNo: HS1520ES
1. To explore stakeholder perceptions of client-centered communication needs for a 4-month DMPA-SC product
2. To explore potential barriers and facilitators to the introduction of a 4-month DMPA-SC product
3. To assess implications for data systems, curriculums, training, supervision, logistics, and quality assurance of introducing a 4-month DMPA-SC product
|
Uganda |
2021-07-06 |
2024-07-06 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|